CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for MicroPort NeuroScientic Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

MicroPort NeuroScientic Corp
No. 1661
Zhangdong Road, Pudong New Area
SHANGHAI, SHA  200000  China Ticker: 21722172

Business Summary
MicroPort NeuroScientic Corp is a company mainly engaged in the research, development and manufacturing of neuro-interventional medical devices. The products cover three areas of cerebrovascular disease, including hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke. The hemorrhagic stroke products mainly include NUMEN coil, NUMEN Silk three dimensional (3D) electronically detachable coil, Nufairy absorbable embolization coil and Tubridge flow-diverting stent. The intracranial atherosclerotic stenosis products mainly include APOLLO intracranial stent, Bridge vertebral artery drug-eluting stent (DES) and Diveer intracranial balloon dilatation catheter. The acute ischemic stroke products mainly include Neurohawk intracranial thrombectomy device, Tigertriever revascularization stent and WAVE-track intracranial aspiration catheter. The products also include auxiliary access devices such as Fastrack microcatheter and U-track intracranial support catheter.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202512/31/2024Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board JieZhang 46 11/14/2025 11/14/2025
President, Executive Director ZhiyongXie 45 11/2/2020 11/2/2020
Advanced Director of Finance ZhuopingHou 44 6/1/2018 6/1/2018
10 additional Officers and Directors records available in full report.

General Information
Number of Employees: 522 (As of 6/30/2025)
Outstanding Shares: 575,531,568 (As of 6/30/2025)
Stock Exchange: HKG


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 7, 2025